For the month ended 31 May 2026, Sisram Medical Ltd reported no changes to either its authorised or issued share capital, underscoring balance-sheet stability and adherence to Hong Kong Stock Exchange requirements.

Authorised Capital • Remained at 1.00 billion ordinary shares with a par value of ILS 0.01, equivalent to authorised capital of ILS 10 million.

Issued Shares • Issued share count stayed at 468.34 million, with zero treasury shares on record. • No share issuances, cancellations, repurchases, or transfers occurred during the month.

Equity Instruments and Corporate Actions • The company reported no outstanding share options, warrants, convertibles, or other agreements that could dilute equity.

Public Float • Sisram Medical confirmed compliance with the Main Board’s minimum 25% public-float requirement as of 31 May 2026.

Administrative Details • The monthly return was filed on 2 June 2026 by Company Secretary Qianli Fang, fulfilling disclosure obligations under Hong Kong Listing Rules.